IYH vs. IDNA
IYH (iShares U.S. Healthcare ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds from iShares - IYH tracks the Dow Jones U.S. Health Care Index while IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index. Both are passively managed. Over the past 5 years, IYH returned 5.19%/yr vs -7.75%/yr for IDNA. A 0.62 correlation means they provide meaningful diversification when combined. IYH charges 0.43%/yr vs 0.47%/yr for IDNA.
Performance
IYH vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IYH achieves a -1.42% return, which is significantly lower than IDNA's 14.39% return.
IYH
- 1D
- 2.89%
- 1M
- 4.56%
- YTD
- -1.42%
- 6M
- -1.04%
- 1Y
- 16.06%
- 3Y*
- 6.36%
- 5Y*
- 5.19%
- 10Y*
- 9.20%
IDNA
- 1D
- 3.70%
- 1M
- 1.49%
- YTD
- 14.39%
- 6M
- 11.58%
- 1Y
- 45.52%
- 3Y*
- 8.39%
- 5Y*
- -7.75%
- 10Y*
- —
IYH vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
IYH iShares U.S. Healthcare ETF | -1.42% | 13.16% | 2.99% | 2.14% | -4.46% | 23.41% | 15.56% | 13.28% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 14.39% | 17.26% | -0.72% | -7.63% | -42.28% | -3.98% | 54.30% | 20.83% |
Correlation
The correlation between IYH and IDNA is 0.65, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.65 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.59 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.60 |
Correlation (All Time) Calculated using the full available price history since Jun 14, 2019 | 0.62 |
The correlation between IYH and IDNA has been stable across timeframes, ranging from 0.59 to 0.65 - a consistent structural relationship.
IYH vs. IDNA - Sectors Allocation Comparison
Sectors
IYH
IDNA
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IYH
IDNA
Basic Materials
IYH
-
IDNA
-
Communication Services
IYH
-
IDNA
-
Consumer Cyclical
IYH
-
IDNA
-
Consumer Defensive
IYH
-
IDNA
-
Energy
IYH
-
IDNA
-
Financial Services
IYH
-
IDNA
-
Industrials
IYH
-
IDNA
Real Estate
IYH
-
IDNA
-
Technology
IYH
-
IDNA
-
Utilities
IYH
-
IDNA
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IYH vs. IDNA — Risk / Return Rank
IYH
IDNA
IYH vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Healthcare ETF (IYH) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IYH | IDNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.78 | ||
| Sortino ratioReturn per unit of downside risk | -0.94 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.30 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 1.52 | 4.29 | -2.77 |
| Martin ratioReturn relative to average drawdown | 3.64 | 12.20 | -8.56 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IYH | IDNA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.07 | 1.85 | -0.78 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.35 | -0.27 | +0.62 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.55 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.12 | +0.31 |
Drawdowns
IYH vs. IDNA - Drawdown Comparison
The maximum IYH drawdown since its inception was -43.12%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for IYH and IDNA.
Loading charts...
Drawdown Indicators
| IYH | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -43.12% | -68.26% | +25.14% |
Max Drawdown (1Y)Largest decline over 1 year | -10.64% | -10.66% | +0.02% |
Max Drawdown (3Y)Largest decline over 3 years | -17.91% | -29.73% | +11.82% |
Max Drawdown (5Y)Largest decline over 5 years | -17.91% | -68.26% | +50.35% |
Max Drawdown (10Y)Largest decline over 10 years | -28.40% | — | — |
Current DrawdownCurrent decline from peak | -4.68% | -43.60% | +38.92% |
Average DrawdownAverage peak-to-trough decline | -8.96% | -36.25% | +27.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.42% | 3.74% | +0.68% |
Volatility
IYH vs. IDNA - Volatility Comparison
The current volatility for iShares U.S. Healthcare ETF (IYH) is 5.06%, while iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a volatility of 8.09%. This indicates that IYH experiences smaller price fluctuations and is considered to be less risky than IDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IYH | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.06% | 8.09% | -3.03% |
Volatility (6M)Calculated over the trailing 6-month period | 10.70% | 18.14% | -7.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.01% | 24.71% | -9.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.97% | 28.46% | -13.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.74% | 29.55% | -12.81% |
IYH vs. IDNA - Expense Ratio Comparison
IYH has a 0.43% expense ratio, which is lower than IDNA's 0.47% expense ratio.
Dividends
IYH vs. IDNA - Dividend Comparison
IYH's dividend yield for the trailing twelve months is around 1.26%, more than IDNA's 1.03% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.03% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% | 0.00% | 0.00% | 0.00% | 0.00% |
IYH iShares U.S. Healthcare ETF | 1.26% | 1.19% | 1.25% | 1.18% | 1.10% | 0.94% | 1.16% | 1.14% | 1.95% | 1.10% | 1.29% | 2.02% |
Frequently Asked Questions
IYH and IDNA have a correlation of 0.65, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDNA has higher volatility (8.09%) compared to IYH (5.06%). In terms of maximum drawdown, IYH dropped -43.12% vs IDNA's -68.26%.
On 5-year performance, IYH leads with 5.19% vs -7.75% for IDNA. On fees, IYH is cheaper at 0.43% per year. On volatility, IYH has been the lower-risk option at 5.06%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, IYH has performed better with a 5.19% return vs -7.75%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IYH is cheaper with a 0.43% expense ratio, compared with 0.47% for IDNA.
IYH has the higher dividend yield at 1.26%, compared with 1.03% for IDNA.
IYH tracks Dow Jones U.S. Health Care Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. Their fees differ too: 0.43% for IYH and 0.47% for IDNA.
IDNA currently has the higher Sharpe Ratio (1.85 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IYH and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer